Hematopoietic Stem-Cell Gene Therapy for Cerebral AdrenoleukodystrophyFlorian Eichler, David A. Williams, Troy C. Lund et al.|New England Journal of Medicine|2017Cited by 592
Long-term follow-up of the first in human post-transcriptional genetic silencing of BCL11A in sickle cell disease in a phase 1 pilot and feasibility trialErica B. Esrick, David A. Williams, Wendy B. London et al.|Blood|2025Cited by 1
Highly efficient collection and manufacture of autologous HSC gene therapy cell product for patients with sickle cell disease using a lentiviral vector containing a shmir targeting BCL11aJohn Manis, David A. Williams, Victoria H. Coleman‐Cowger et al.|Blood|2025Cited by 1